Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of conduct to regulate, monitor and report trading in Securities of the Company, KMS Medisurgi has informed that it has enclosed the Trading Window for trading in the Securities of the Company will remain closed with effect from October 01, 2020 till Forty-Eight hours after the declaration of Unaudited Financial Results of the Company for the half year ended September 30, 2020.
The above information is a part of company’s filings submitted to BSE.